New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Actuate Therapeutics, Inc. (ACTU) vs Tvardi Therapeutics, Inc. (TVRD)
- Actuate Therapeutics, Inc. ACTU 0.23 +9.52%
- Tvardi Therapeutics, Inc. TVRD 0.99 +4.21%
Actuate Therapeutics, Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and Tvardi Therapeutics, Inc. are of similar size ($12.9M and $12.6M). Across the 7 metrics below, Tvardi Therapeutics, Inc. leads on 6 and Actuate Therapeutics, Inc. on 1.
Valuation
Profitability
| Metric | ACTU | TVRD | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 146.85% | 70.18% |
| Operating margin | — | (36.92%) | 0.00% |
| Net margin | — | (459.31%) | 0.00% |
| Free cash flow margin | — | 58.90% | 0.00% |
| Return on equity | (364.70%) | (123.08%) | (51.58%) |
| Return on assets | (176.44%) | (85.24%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack